About
Biomarker Cancer Diagnostics
Areas of Focus
Categories
Diagnostics
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
120
By Phase
NA: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Today
Hover over trial bars to see details
Recent Trials
NCT05977036Collaborator
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
NARecruiting
65 participants
Started: Sep 25, 2024 · Completed: Sep 30, 2034
NCT04968964Collaborator
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
NARecruiting
55 participants
Started: Mar 7, 2022 · Completed: Sep 30, 2029
Locations (1)
Headquarters
Uppsala, Sweden
Map
Loading map...